CHG-2021-0252
Container Closure Change for Respiralimab. Facility Change for Respiralimab — critical change. Impacts 2 markets and 2 variations.
Change Number
CHG-2021-0252
Type
Container Closure Change
Product
Status
Completed
Owner
Nadia Petrova
Initiated
2022-11-13
Description
Facility Change for Respiralimab — critical change
Impacted Markets (2)
US — United StatesDK — Denmark
Impacted Modules
4.2.13.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|